Physician profile
Thomas E Mccauley
NPI 1861452336
$982.26
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $456 · 2020: $349 · 2021: $23.69 · 2022: $74.76 · 2024: $79.45.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $79.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $79.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $195.07 | 2020-2024 | |
| Astrazeneca Pharmaceuticals Lp | $154.84 | 2019-2020 | |
| Amgen INC. | $109.17 | 2019-2020 | |
| Novo Nordisk INC | $67.98 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.75 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $48.23 | 2019 | |
| Boston Scientific Corporation | $42.88 | 2019-2024 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.27 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $28.29 | 2020 | |
| Lilly USA, LLC | $27.42 | 2019 | |
| Pfizer INC. | $26.80 | 2020 | |
| Medtronic USA, INC. | $26.77 | 2019 | |
| Glaxosmithkline, LLC. | $20.54 | 2020 | |
| Upsher-Smith Laboratories LLC | $19.80 | 2020 | |
| Strongbridge US INC. | $17.66 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17.45 | 2020 | |
| Emergent Biosolutions INC. | $16.91 | 2019 | |
| Amarin Pharma, INC. | $15.94 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $15.81 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $14.01 | 2020 | |
| Merck Sharp & Dohme LLC | $13.69 | 2019 | |
| Hologic Sales and Service, LLC | $12.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Mccauley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.